MENU

Eric A. Ross, PhD, ScM

Eric A. Ross, PhD, ScM

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

Assistant Vice President of Biometrics and Information Sciences

Director, Biostatistics and Bioinformatics Facility

Director, Population Studies Facility

Associate Research Professor

Research Program

Educational Background

  • PhD, Statistics, Temple University, 1996
  • ScM, Biostatistics, Bloomberg School of Public Health, The Johns Hopkins University, 1984
  • BA, Biological Sciences, University of Delaware, 1980

Memberships

  • American Statistical Association, member
  • International Biometrics Society, member
  • American Medical Informatics Association, member
  • Society for Clinical Trials, member 

Research Program

Research Interests

  • Development of new randomized phase II clinical trial designs.
  • Application of state of the art statistical approaches to rigorously extend the quantitative interpretation of data.
  • Large-scale data integration, and the development and application of web-based technologies to enable remote data collection/presentation, health education and new interventions.

Lab Overview

Our research focuses on the innovative use of quantitative methods and information technology in cancer research. Our statistical methodology research includes development and application of novel methods for the analysis of correlated failure time and high throughput laboratory data. We are also interested in the creation of new randomized Phase II clinical trial designs that permit early stopping in both patient number and time of initial evaluation. These designs provide for early termination for futility or efficacy, and should be particularly appropriate for studies in patient populations with a high likelihood for rapid disease progression. Our collaborations with numerous investigators conducting clinical, translational, cancer control, epidemiology, and basic science research rigorously extend the quantitative interpretation of results from these disciplines. Our informatics research facilitates cancer investigations by promoting the use of computer-based methods that improve research efficiency and data quality. Special areas of interest include large-scale data integration, and the development and application of web-based technologies to enable remote data collection/presentation, health education and new interventions.

People

Tianya Li, MS

Senior Research Biostatistician

Room: R383
215-728-4747

Karen Ruth, MS

Senior Research Biostatistician

Room: R383
215-728-3084

Michael Slifker, MS

Senior Programmer Analyst

Room: R383
215-728-5345

Yan Zhou, MSE, PhD

Assistant Research Professor

Room: R431
215-728-3780

Beth Handorf, PhD

Instructor

Room: R383
215-728-4773

Olga Tchuvatkina, MS

Manager of Population Studies Facility

Room: 239 Laurel Avenue
215-214-1494

Christine Huang, MS

Software Architect

Room: 241 Laurel Avenue
215-728-3641

Stanford Taylor, MS

Data Warehouse Architect

Room: 228 Laurel Avenue
215-214-1493

Pawel Przybysz, BS

Programmer Analyst

Room: 235 Laurel Avenue
215-728-2708

Shiju Daniel, BS

Senior Programmer Analyst

Room: 237 Laurel Avenue
215-728-5385

Carol Carey

Data Manager

Room: 231 Laurel Avenue
215-728-5286

Selected Publications

   Plimack, ER, Dunbrack, R, Brennan, T, Andrake, M, Zhou, Y, Serebriiskii, I, Wei, Q, Slifker, M, Alpaugh, K, Dulaimi, E, Palma, N, Hoffman-Censits, J, Bilusic, M, Wong, YN, Kutikov, A, Viterbo, R, Greenberg, RE, Chen, D, Lallas, CD, Trabulski, EJ, Yelensky, R, McConkey, D, Miller, VA, Golemis, E, Ross, E.  Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer. Eur Urol. 2015; epub ahead of print   PubMed

 

 Weinberg DS, Myers RE, Keenan E, Ruth K, Sifri R, Ziring B, Ross E, Manne SL. Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med. 2014 Oct 21;161(8):537-45. PubMed PMID: 25329201; PubMed Central PMCID: PMC4412019. PubMed

 

   Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity. J Clin Oncol. 2014 Jun 20;32(18):1895-901. PubMed PMID: 24821881; PubMed Central PMCID: PMC4050203.  PubMed

 

  Min H, Ohira R, Collins MA, Bondy J, Avis NE, Tchuvatkina O, Courtney PK, Moser RP, Shaikh AR, Hesse BW, Cooper M, Reeves D, Lanese B, Helba C, Miller SM, Ross EA. Sharing behavioral data through a grid infrastructure using data standards. J Am Med Inform Assoc. 2014 Jul-Aug;21(4):642-9. PubMed PMID: 24076749; PubMed Central PMCID: PMC4078270.  PubMed

 

  Handorf E, Ross EA. Uncertainty in pilot parameter estimates: A comparison of methods to size full trials. Proceedings of the American Statistical Association, Statistics Section; 2013; Toronto, Canada. c2015.   PubMed

 

 Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, Boraas M, Topham NS, Egleston BL. Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol. 2012 Dec 20;30(36):4485-92. PubMed PMID: 23169513; PubMed Central PMCID: PMC3518727.   PubMed

 

 Ariazi EA, Cunliffe HE, Lewis-Wambi JS, Slifker MJ, Willis AL, Ramos P, Tapia C, Kim HR, Yerrum S, Sharma CG, Nicolas E, Balagurunathan Y, Ross EA, Jordan VC. Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time. Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18879-86. PubMed PMID: 22011582; PubMed Central PMCID: PMC3223472.    PubMed

 

 Schilder RJ, Pathak HB, Lokshin AE, Holloway RW, Alvarez RD, Aghajanian C, Min H, Devarajan K, Ross E, Drescher CW, Godwin AK. Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecol Oncol. 2009 Apr;113(1):21-7. PubMed PMID: 19162309; PubMed Central PMCID: PMC2741166.   PubMed

 

 Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst. 2005 Dec 7;97(23):1746-59. PubMed PMID: 16333030.   PubMed

 

Stoyanova R, Clapper ML, Bellacosa A, Henske EP, Testa JR, Ross EA, Yeung AT, Nicolas E, Tsichlis N, Li YS, Linehan WM, Howard S, Campbell KS, Godwin AK, Boman BM, Crowell JA, Kopelovich L, Knudson AG. Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer Biol Ther. 2004 Dec;3(12):1313-21. PubMed PMID: 15662135.   PubMed

 

 Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):369-76. PubMed PMID: 11927497.     PubMed    

 

  Daly MB, Ross EA. Predicting breast cancer: the search for a model. J Natl Cancer Inst. 2000 Aug 2;92(15):1196-7. PubMed PMID: 10922397.       PubMed

 

  Ross EA, Moore D. Modeling clustered, discrete, or grouped time survival data with covariates. Biometrics. 1999 Sep;55(3):813-9. PubMed PMID: 11315011.     PubMed  

 

 Hudes G, Einhorn L, Ross E, Balsham A, Loehrer P, Ramsey H, Sprandio J, Entmacher M, Dugan W, Ansari R, Monaco F, Hanna M, Roth B. Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase Network phase III trial. J Clin Oncol. 1999 Oct;17(10):3160-6. PubMed PMID: 10506613.     PubMed

 

 Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst. 1994 Apr 20;86(8):620-5. PubMed PMID: 8003106.     PubMed

 

Additional Publications

My NCBI